dt 5461 has been researched along with herbimycin in 1 studies
Studies (dt 5461) | Trials (dt 5461) | Recent Studies (post-2010) (dt 5461) | Studies (herbimycin) | Trials (herbimycin) | Recent Studies (post-2010) (herbimycin) |
---|---|---|---|---|---|
16 | 0 | 0 | 912 | 0 | 26 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akimoto, T; Joto, N; Someya, K; Tohgo, A | 1 |
1 other study(ies) available for dt 5461 and herbimycin
Article | Year |
---|---|
Production of tumor necrosis factor induced by synthetic low-toxicity lipid A analog, DT-5461a, is mediated by LPS receptor sites and tyrosine kinase-MAP kinase signaling pathway in murine macrophages.
Topics: Animals; Benzoquinones; Binding, Competitive; Blotting, Western; Cell Line, Transformed; Disaccharides; Lactams, Macrocyclic; Lipid A; Lipopolysaccharide Receptors; Lipopolysaccharides; Macrophages; Mice; Protein Kinases; Protein-Tyrosine Kinases; Quinones; Receptors, Immunologic; Rifabutin; RNA, Messenger; Signal Transduction; Tumor Necrosis Factor-alpha | 1995 |